Shield Therapeutics Community

Key Takeaways An expanding addressable market and greater screening activity are driving strong prescription growth and recurring revenues for Shield's main product. Strategic partnerships, international expansion, and improved operational efficiency are positioned to enhance margins and drive sustained profit growth.